Approval · Notice of Compliance 30332 · 2023
TULAJECT: Notice of Compliance 30332
Issued March 16, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30332
- Date
- March 16, 2023
- Company
- Alivira Animal Health LimitedDublin D02, Ireland
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- DRAXXIN (Zoetis Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TULAJECT | 02536013 | Approved |
Medicinal ingredients
- TULATHROMYCIN 100 MG per ML